Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT07388758 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07388758
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2028-02-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.